Clin Endosc.  2017 Nov;50(6):514-515. 10.5946/ce.2017.159.

Clinical Significance of Risk Factors for Asymptomatic Peptic Ulcer Disease

• Huh CW
• Kim BW

• KMID: 2398299
• DOI: http://doi.org/10.5946/ce.2017.159

Abstract

No abstract available.

MeSH Terms

Peptic Ulcer*
Risk Factors*

Reference

1. Lanas A, Chan FKL. Peptic ulcer disease. Lancet. 2017; 390:613–624.

2. Yeo SH, Yang CH. [Peptic ulcer disease associated with Helicobacter pylori infection]. Korean J Gastroenterol. 2016; 67:289–299.

3. Kim HS, Baik SJ, Kim KH, et al. Prevalence of and risk factors for gastrointestinal diseases in Korean Americans and native Koreans undergoing screening endoscopy. Gut Liver. 2013; 7:539–545.

4. Kim JJ, Kim N, Park HK, et al. [Clinical characteristics of patients diagnosed as peptic ulcer disease in the third referral center in 2007]. Korean J Gastroenterol. 2012; 59:338–346.

5. Wang AY, Peura DA. The prevalence and incidence of Helicobacter pylori-associated peptic ulcer disease and upper gastrointestinal bleeding throughout the world. Gastrointest Endosc Clin N Am. 2011; 21:613–635.

6. Sung JJ, Kuipers EJ, El-Serag HB. Systematic review: the global incidence and prevalence of peptic ulcer disease. Aliment Pharmacol Ther. 2009; 29:938–946.

7. Manuel D, Cutler A, Goldstein J, Fennerty MB, Brown K. Decreasing prevalence combined with increasing eradication of Helicobacter pylori infection in the United States has not resulted in fewer hospital admissions for peptic ulcer disease-related complications. Aliment Pharmacol Ther. 2007; 25:1423–1427.

8. Bae S, Shim KN, Kim N, et al. Incidence and short-term mortality from perforated peptic ulcer in Korea: a population-based study. J Epidemiol. 2012; 22:508–516.

9. Kang JM, Kim N, Kim JH, et al. Effect of aging on gastric mucosal defense mechanisms: ROS, apoptosis, angiogenesis, and sensory neurons. Am J Physiol Gastrointest Liver Physiol. 2010; 299:G1147–G1153.

10. Wang FW, Tu MS, Mar GY, et al. Prevalence and risk factors of asymptomatic peptic ulcer disease in Taiwan. World J Gastroenterol. 2011; 17:1199–1203.

11. Lu CL, Chang SS, Wang SS, Chang FY, Lee SD. Silent peptic ulcer disease: frequency, factors leading to “silence,” and implications regarding the pathogenesis of visceral symptoms. Gastrointest Endosc. 2004; 60:34–38.

12. Wilcox CM, Clark WS. Features associated with painless peptic ulcer bleeding. Am J Gastroenterol. 1997; 92:1289–1292.

13. Pounder R. Silent peptic ulceration: deadly silence or golden silence? Gastroenterology. 1989; 96(2 Pt 2 Suppl):626–631.

14. Kim HM, Cho JH, Choi JY, et al. NSAID is inversely associated with asymptomatic gastric ulcer: local health examination data from the Korean national health insurance corporation. Scand J Gastroenterol. 2013; 48:1371–1376.

15. Lee SP, Sung IK, Kim JH, Lee SY, Park HS, Shim CS. Risk factors for the presence of symptoms in peptic ulcer disease. Clin Endosc Clin Endosc. 2017; 50:578–584.